BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Encainide

One of the ANTI-ARRHYTHMIA AGENTS, it blocks VOLTAGE-GATED SODIUM CHANNELS and slows conduction within the His-Purkinje system and MYOCARDIUM.

300+ PubMed studies analyzed · 35 RCTs · Evidence Score: 52.7

Research Domains

Encainide has been studied across 11 research domains including ❤️ Cardiovascular, 😴 Sleep, 🫁 Liver & Detox, 🦴 Bone & Joint, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 85% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Encainide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Psilocybin
3 shared targets
Aprindine
4 shared targets
Nefopam
5 shared targets
sb
2 shared targets
rs
2 shared targets
azelastine
3 shared targets
nn
2 shared targets
lorcaserin
2 shared targets
sb
2 shared targets
alosetron
2 shared targets
Loading evidence profile...

This evidence profile for Encainide is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.